CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 170 enrolled
Drug / intervention
Web-based Surveyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03072303
NCT03072303N/ACompleted

Pregnancy in Osteogenesis Imperfecta (OI) Registry

University of South Florida·observational·Posted Mar 7, 2017·Updated Oct 16, 2019

In Brief

An observational study evaluating Web-based Survey for Osteogenesis Imperfecta and Brittle Bone Disorders. Completed, enrolled 170 participants across 1 site.

Detailed Summary

The purpose of this study is to learn about pregnancy outcomes in osteogenesis imperfecta (OI). Patients enrolled in the Brittle Bone Disorders (BBD) Contact Registry (CR) will be invited via email to participate in this study.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 7, 2017
Enrollment StartJun 16, 2017
Primary CompletionMar 13, 2019
Study CompletionSep 13, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.3 years ago

Interventions

Web-based Surveyother

Patients will be sent an email invitation describing the study. If the participant wants to participate and is eligible, she will follow the survey link in the email message, which directs her to an IRB-approved online consent form. A unique survey link will be generated for each participant and included in the survey invitation, which is a customized email message. This link will allow the investigators to determine who completed the survey. The investigators will send repeat email invitations every two months (total of 3 invitations) to those invitees who have not yet participated. The investigators will allow approximately 6 months for enrollment and survey completion and expect that the study will close soon thereafter.